Melgain Lotion (Decapeptide) – Vitiligo Treatment & Skin Repigmentation Solution

Buy Melgain Lotion from Tabexports – Global Medicine Exporter

Melgain Lotion (Decapeptide) is a dermatological treatment used for the management of vitiligo and skin depigmentation disorders. It contains Decapeptide, a bioactive peptide that helps stimulate melanin production and repigmentation of the skin, assisting in restoring the natural skin color.

Tabexports supplies Melgain Lotion for international pharmaceutical markets, offering bulk export, wholesale supply, and reliable global shipping to United States, United Kingdom, Australia, France, Thailand, and worldwide pharmaceutical distributors.

Active Ingredient

• Decapeptide

Decapeptide works by stimulating melanocyte activity, helping the skin produce melanin pigment and gradually restore natural skin color in depigmented areas.

Medical Uses

✔ Treatment of vitiligo (white patches on skin)
✔ Support for skin repigmentation therapy
✔ Management of hypopigmentation disorders
✔ Dermatological treatment to restore natural skin tone
✔ Helps improve melanin production in affected areas

⚠ Use under the supervision of a healthcare professional.

Key Benefits

• Helps stimulate natural skin pigmentation

• Supports repigmentation in vitiligo patches

• Non-steroidal dermatological treatment

• Widely prescribed by dermatologists

• Suitable for long-term vitiligo management

Directions for Use

1. Clean and dry the affected area.

2. Apply a small amount of Melgain Lotion to the depigmented skin.

3. Gently massage until absorbed.

4. Use regularly as prescribed by a healthcare professional.

Storage Instructions

• Store below 25°C

• Keep away from direct sunlight

• Keep out of reach of children

Why Choose Tabexports?

🌍 Worldwide pharmaceutical exporter
📦 Bulk supply for distributors and wholesalers
🚚 Reliable international shipping
🏭 High-quality pharmaceutical sourcing
📈 Trusted supplier for global pharmacies and healthcare markets

Tabexports exports Melgain Lotion (Decapeptide) to USA, UK, Australia, France, Thailand, and worldwide pharmaceutical markets.